Facebook
Instagram
Twitter
Vimeo
Youtube
Investor News
Business
Cannabis
Featured News
Medical
Mining
Search
MoMo Gains
Investor News
Wednesday, May 15, 2024
MoMo Gains
Investor News
Investor News
Business
Cannabis
Featured News
Medical
Mining
Search
Home
NRBO
NRBO
Breaking News
NeuroBo (NASDAQ: NRBO) Flying on FDA Clearance of IND for Phase 1 Obesity Treatment Clinical Trial
editor
-
February 1, 2024
Breaking News
NeuroBo Pharmaceuticals Announces FDA Clearance of IND for a Phase 1 Clinical Trial of DA-1726 for the Treatment of Obesity
editor
-
February 1, 2024
No posts to display
- Advertisment -
Most Read
US Companies Moving the Markets, Evening edition Tue, May 14, 2024 as of 4:00 pm ET
May 14, 2024
Investigation Into Inotiv, Inc. (NOTV) Announced by Holzer & Holzer, LLC
May 14, 2024
US Companies Moving the Markets, Morning edition Tue, May 14, 2024 as of 10.00 am ET
May 14, 2024
Inotiv, Inc. to Report Fiscal 2024 Second Quarter Financial Results and Host Conference Call on Wednesday, May 15, 2024
May 14, 2024
editor
